Safa, B. Et Al. 2012. 25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective?. 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Geneva, Switzerland), 34.

Safa, B., Karakoc-Aydiner, E., Cagan, H., Kiykim, A., Tulunay, A., Akkoc, T., ... Barlan, I.(2012). 25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective? . 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.34). Geneva, Switzerland

Safa, B. Et Al. "25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective?," 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Geneva, Switzerland, 2012

Safa, B. Et Al. "25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective?." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, pp.34, 2012

Safa, B. Et Al. (2012) . "25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective?." 31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Geneva, Switzerland, p.34.

@conferencepaper{conferencepaper, author={B. Safa Et Al. }, title={25 (OH) vitamin D-3 as an adjunct to subcutaneous allergen immunotherapy: is it effective?}, congress name={31st Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={34} }